D-Dimer Test Market 2019-2028: Consumption Growth Rate, Market Drivers and Opportunities
A D-dimer test is a blood test which is used to help check or monitor blood clotting problems in human. Blood clots causes various health problems such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke and disseminated intravascular coagulation (DIC). D-dimer is formed when the blood clots are dissolve in body. D-dimer is a protein fragment from the breakdown of a blood clots. Blood clots begin to slowly break down after they are formed, and this process releases d-dimer into the blood. The d-dimer test is done by drawing blood sample through need from arm. D-dimer levels are increased in patient suffering from intravascular coagulation, recent bleeding, hematoma, trauma, surgical operation, thromboembolism, liver disease and malignancy.
To get more insights, visit: https://marketresearch.biz/report/d-dimer-test-market/
A blood clot that forms in a deep vein is called a deep vein thrombosis (DVT) and is mostly found in legs. If the clot travels to the lungs, it’s results in pulmonary embolism (PE) which cuts off the flow of blood. This two term are collective called as Venous thromboembolism (VTE), which is anticipated to boost the growth of d-dimer test market globally. In addition, increasing incidence of chronic disease such as clots in coronary arteries are the cause of myocardial infarction (heart attacks), clots in large arteries as a result of narrowing and damage from atherosclerosis and rising prevalence of blood related disorder such as bleeding problems, blood cancers etc. are some of the other factors that are anticipated to boost the growth of d-dimer test globally.
The factor hindering the growth of d-dimer test market are increase geriatrics population which creates a problem for interpretation d-dimer test level due to many fluctuations in certain factors that arise due to aging.
The use of D-dimer level acts as viable solution for coagulopathy, inflammatory response, and mortality in the critically ill patient. Investigators are currently examining the extended use of D-dimer tests for other disease states and processes.
The global d-dimer test market has been segmented on the basis of testing methods, end-use verticals, disease type and region. On the basis of region, market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among all the region, the market in North America dominates the global d-dimer test market owing to the high number of people suffering from chronic blood disorders. Asia-Pacific is expected to register the highest CAGR during the forecast period owing to the factors such as expansion of hospitals and healthcare centers.
For sample copy of the report, please click: https://marketresearch.biz/report/d-dimer-test-market/request-sample/
The key players in global d-dimer test markets are, Abbott Laboratories, Inc., Beckman Coulter Inc., Thermo & Fischer Scientific, Inc., Becton, Dickinson and Company, Trinity Biotech plc., Beckman Coulter, Inc., Bio/Data Corporation, Siemens Healthcare, Helena Biosciences, and Sysmex Corporation